Integral Diagnostics (ASX:IDX) EV-to-EBITDA : 73.32 (As of May. 22, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Integral Diagnostics EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Integral Diagnostics's enterprise value is A$921.4 Mil. Integral Diagnostics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$12.6 Mil. Therefore, Integral Diagnostics's EV-to-EBITDA for today is 73.32.

The historical rank and industry rank for Integral Diagnostics's EV-to-EBITDA or its related term are showing as below:

ASX:IDX' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.03 Med: 12.13 Max: 73.7
Current: 73.33

During the past 8 years, the highest EV-to-EBITDA of Integral Diagnostics was 73.70. The lowest was 7.03. And the median was 12.13.

ASX:IDX's EV-to-EBITDA is ranked worse than
95.61% of 114 companies
in the Medical Diagnostics & Research industry
Industry Median: 16.635 vs ASX:IDX: 73.33

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), Integral Diagnostics's stock price is A$2.47. Integral Diagnostics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.248. Therefore, Integral Diagnostics's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Integral Diagnostics EV-to-EBITDA Historical Data

The historical data trend for Integral Diagnostics's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integral Diagnostics EV-to-EBITDA Chart

Integral Diagnostics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-EBITDA

Get a 7-Day Free Trial

12.21

14.09

14.36

13.07

11.85

Integral Diagnostics Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial												-	13.07	-	11.85	-

Competitive Comparison of Integral Diagnostics's EV-to-EBITDA

For the Diagnostics & Research subindustry, Integral Diagnostics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integral Diagnostics's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integral Diagnostics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Integral Diagnostics's EV-to-EBITDA falls into.

Integral Diagnostics EV-to-EBITDA Calculation

Integral Diagnostics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	921.390	/	12.566
	=	73.32

Integral Diagnostics's current Enterprise Value is A$921.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Integral Diagnostics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$12.6 Mil.

Integral Diagnostics (ASX:IDX) EV-to-EBITDA Explanation

Integral Diagnostics's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	2.47	/	-0.248
	=	At Loss

Integral Diagnostics's share price for today is A$2.47.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Integral Diagnostics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.248.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Integral Diagnostics EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Integral Diagnostics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Integral Diagnostics (ASX:IDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integral Diagnostics Ltd (ASX:IDX) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

ITGDF:USA

Address

45 William Street, Suite 9.02, Level 9, Melbourne, VIC, AUS, 3000

Website

http://www.integraldiagnostics.com.au

Integral Diagnostics is Australia's fourth-largest diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.